Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

Neville K Kisalu^#¹, Azza H Idris^#¹, Connor Weidle², Yevel Flores-Garcia³, Barbara J Flynn¹, Brandon K Sack⁴, Sean Murphy⁴, Arne Schön⁵, Ernesto Freire⁵, Joseph R Francica¹, Alex B Miller⁶, Jason Gregory³, Sandra March⁶, Hua-Xin Liao^{7

8}, Barton F Haynes^{7

9

10}, Kevin Wiehe^{7

9}, Ashley M Trama⁷, Kevin O Saunders^{7

11}, Morgan A Gladden⁷, Anthony Monroe⁷, Mattia Bonsignori^{7

9}, Masaru Kanekiyo¹, Adam K Wheatley^{1

12}, Adrian B McDermott¹, S Katie Farney¹, Gwo-Yu Chuang¹, Baoshan Zhang¹, Natasha Kc¹³, Sumana Chakravarty¹³, Peter D Kwong¹, Photini Sinnis³, Sangeeta N Bhatia⁶, Stefan H I Kappe⁴, B Kim Lee Sim¹³, Stephen L Hoffman¹³, Fidel Zavala³, Marie Pancera^#¹⁴, Robert A Seder^#¹⁵

Affiliations

¹ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
² Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
³ Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
⁴ Seattle Biomedical Research Institute, Seattle, Washington, USA.
⁵ Department of Biology, Johns Hopkins University, Baltimore, Maryland, USA.
⁶ Division of Health Sciences and Technology, Institute for Medical Engineering and Science, and The Broad Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
⁷ Duke Human Vaccine Institute, Durham, North Carolina, USA.
⁸ College of Life Science and Technology, Jinan University, Guangzhou, China.
⁹ Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
¹⁰ Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.
¹¹ Department of Surgery, Duke University School of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
¹² Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
¹³ Sanaria Inc., Rockville, Maryland, USA.
¹⁴ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. mpancera@fredhutch.org.
¹⁵ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. rseder@mail.nih.gov.

^# Contributed equally.

PMID: 30552419
DOI: 10.1038/s41591-018-0315-0

Published Erratum

Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

Neville K Kisalu et al. Nat Med. 2019 Jan.

. 2019 Jan;25(1):188-189.

doi: 10.1038/s41591-018-0315-0.

Authors

Affiliations

¹ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
² Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
³ Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
⁴ Seattle Biomedical Research Institute, Seattle, Washington, USA.
⁵ Department of Biology, Johns Hopkins University, Baltimore, Maryland, USA.
⁶ Division of Health Sciences and Technology, Institute for Medical Engineering and Science, and The Broad Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
⁷ Duke Human Vaccine Institute, Durham, North Carolina, USA.
⁸ College of Life Science and Technology, Jinan University, Guangzhou, China.
⁹ Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
¹⁰ Department of Immunology, Duke University Medical Center, Durham, North Carolina, USA.
¹¹ Department of Surgery, Duke University School of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
¹² Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
¹³ Sanaria Inc., Rockville, Maryland, USA.
¹⁴ Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. mpancera@fredhutch.org.
¹⁵ Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. rseder@mail.nih.gov.

^# Contributed equally.

PMID: 30552419
DOI: 10.1038/s41591-018-0315-0

Abstract

In the version of this article originally published, data were incorrectly ascribed to monoclonal antibody CIS34 because of a labeling error. The data were generated with monoclonal antibody CIS04. Full details can be found in the correction notice.

PubMed Disclaimer

Erratum for

A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.
Kisalu NK, Idris AH, Weidle C, Flores-Garcia Y, Flynn BJ, Sack BK, Murphy S, Schön A, Freire E, Francica JR, Miller AB, Gregory J, March S, Liao HX, Haynes BF, Wiehe K, Trama AM, Saunders KO, Gladden MA, Monroe A, Bonsignori M, Kanekiyo M, Wheatley AK, McDermott AB, Farney SK, Chuang GY, Zhang B, Kc N, Chakravarty S, Kwong PD, Sinnis P, Bhatia SN, Kappe SHI, Sim BKL, Hoffman SL, Zavala F, Pancera M, Seder RA. Kisalu NK, et al. Nat Med. 2018 May;24(4):408-416. doi: 10.1038/nm.4512. Epub 2018 Mar 19. Nat Med. 2018. PMID: 29554083 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

Affiliations

Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources